Abstract
The increase in detection of alprazolam among cases of HRD, particularly since 2005, and the disproportionate increase in prescribing of the high-dose 2 mg formulation compared with other formulations suggest a need to examine alprazolam prescribing and to identify inappropriate prescribing and the circumstances of diversion from licit to illicit use.
| Original language | English |
|---|---|
| Pages (from-to) | 206 - 209 |
| Number of pages | 4 |
| Journal | The Medical Journal of Australia |
| Volume | 198 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2013 |